Gene · 6900
Papers4,207
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,207
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting CD24 as a novel immunotherapy for solid cancers. | Cell Commun Signal | 2023 | 37919766 | PubTator, text mining | PubMed |
| Engineered small extracellular vesicles as a novel platform to suppress human oncovirus-associated cancers. | Infect Agent Cancer | 2023 | 37915098 | PubTator, text mining | PubMed |
| Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. | Cell Rep Med | 2023 | 37909041 | PubTator, text mining | PubMed |
| African swine fever virus B175L inhibits the type I interferon pathway by targeting STING and 2'3'-cGAMP. | J Virol | 2023 | 37902401 | PubTator, text mining | PubMed |
Upfront Taxane Could Be Superior to Pegylated Liposomal Doxorubicin (PLD): A Retrospective Real-World Analysis of Treatment Sequence Taxane-PLD versus PLD-Taxane in Patients with Metastatic Breast Cancer. | Cancers (Basel) | 2023 | 37894320 | PubTator, text mining | PubMed |
| Understanding the Immunopathology of HTLV-1-Associated Adult T-Cell Leukemia/Lymphoma: A Comprehensive Review. | Biomolecules | 2023 | 37892225 | PubTator, text mining | PubMed |
| HTLV-1 biofilm polarization maintained by tetraspanin CD82 is required for efficient viral transmission. | mBio | 2023 | 37889017 | PubTator, text mining | PubMed |
| Challenges involved in cell therapy for Parkinson's disease using human pluripotent stem cells. | Front Cell Dev Biol | 2023 | 37886394 | PubTator, text mining | PubMed |
| Antibody-directed extracellular proximity biotinylation reveals that Contactin-1 regulates axo-axonic innervation of axon initial segments. | Nat Commun | 2023 | 37884508 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection establishes a stable and age-independent CD8+ T cell response against a dominant nucleocapsid epitope using restricted T cell receptors. | Nat Commun | 2023 | 37872153 | PubTator, text mining | PubMed |
| University-industry collaboration as a driver of digital transformation: Types, benefits and enablers. | Heliyon | 2023 | 37867890 | PubTator, text mining | PubMed |
| Developing mitochondrial base editors with diverse context compatibility and high fidelity via saturated spacer library. | Nat Commun | 2023 | 37857619 | PubTator, text mining | PubMed |
| Recurrent DNMT3B rearrangements are associated with unfavorable outcome in dicentric (9;20)-positive pediatric BCP-ALL. | Leukemia | 2023 | 37845283 | PubTator, text mining | PubMed |
| Research Progress of Dihydroquercetin in the Treatment of Skin Diseases. | Molecules | 2023 | 37836832 | PubTator, text mining | PubMed |
| Human T-Cell Leukemia Virus Type 1 Oncogenesis between Active Expression and Latency: A Possible Source for the Development of Therapeutic Targets. | Int J Mol Sci | 2023 | 37834255 | PubTator, text mining | PubMed |
| Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions. | Int J Mol Sci | 2023 | 37834078 | PubTator, text mining | PubMed |
| Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach. | Virus Res | 2023 | 37832654 | PubTator, text mining | PubMed |
| Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. | Mol Cancer | 2023 | 37814270 | PubTator, text mining | PubMed |
| Recovering lost tax to meet the health financing gap for universal public sector health systems in East and Southern Africa. | BMJ Glob Health | 2023 | 37813446 | PubTator, text mining | PubMed |
| Considerations for modelling a broad food tax in the Philippines and other low-income and middle-income countries. | BMJ Glob Health | 2023 | 37813445 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6900/papers?page=15